Kraig Biocraft Laboratories' spring production trials for recombinant spider silk, BAM-1, exceeded expectations.
Kraig Biocraft Laboratories' spring production trials for recombinant spider silk, BAM-1, exceeded expectations, demonstrating parental lines ready for rapid expansion. CEO Kim Thompson and Dr. Nirmal Kumar led successful trials, with improved reeling characteristics and higher yields, unique luster & strength. This success prepares the company for operations expansion across multiple countries.
May 06, 2024
3 Articles